Clinical Trial Update: Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients. [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial investigated intranasal oxytocin to reduce relapse risk in cocaine-dependent patients; the study has completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Dependence

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cocaine Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-11-29